Back to Clinical Trials Overview

Back To Cancer Clinical Trials

Your search for "Lung" returned 5 results:


Effects of a dietary supplement (SV) on advanced non small cell lung cancer patients treated with best supportive care (BSC): A randomized double-blind placebo controlled study, a phase III Trial
Principal Investigator(s): Henry Sacks

A Phase III, Randomised, Double-blind, Placebo-controlled, Multi-centre, International Study of MEDI4736 as Sequential Therapy in Patients with Locally Advanced, Unresectable Non-Small Cell Lung Cancer (Stage III) Who Have Not Progressed Following Definitive, Platinum-based, Concurrent Chemoradiation Therapy (PACIFIC) (Protocol# D4191C00001)
Principal Investigator(s): Dr. Jorge Gomez

METformin with a caRbOhydrate restricted diet in combination with platinum based chemotherapy in stage IIIB/IV non-squamous non-small cell lung cancer (NS-NSCLC) – METRO study
Principal Investigator(s): Dr. Jorge Gomez

A Randomized Phase II Study of Individualized Combined Modality Therapy for Stage III Non-Small Cell Lung Cancer (NSCLC)
Principal Investigator(s): Dr. Jorge Gomez

A Phase III, Open-label, Randomised, Multi-centre, International Study of MEDI4736, Given as Monotherapy or in Combination with Tremelimumab, Determined by PD-L1 Expression, Versus Standard of Care in Patients with Locally Advanced or Metastatic Non-Small Cell Lung Cancer (Stage IIIB IV) who Have Received at Least Two Prior Systemic Treatment Regimens Including One Platinum based Chemotherapy Regimen and Do Not Have Known EGFR TK Activating Mutations or ALK Rearrangements (ARCTIC)
Principal Investigator(s): Dr. Jorge Gomez